Company profile: Clarivate
1.1 - Company Overview
Company description
- Provider of trusted insights, analytics, data, workflow solutions, and deep domain expertise that help innovators discover, protect, and commercialize ideas faster. Offers real-world healthcare data, formulary tools, patient identification and assistance, and consulting in commercial strategy, evidence/value/access, and technology, including systems integration, data informatics, and custom solutions.
Products and services
- Real-World Data: Delivers enterprise-grade insights from healthcare data products for research, investigating patient populations and clinical outcomes
- Evidence, Value and Access Consulting: Delivers methodology-driven technical consulting across the product journey, focusing on maximizing evidence value for successful access and reimbursement strategies
- Commercial Strategy Consulting: Offers analytics-driven consulting for biopharmaceutical and MedTech clients, covering market assessments, product positioning, and launch strategies
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Clarivate
eMolecules
HQ: United States
Website
- Description: Provider of a free chemical structure search engine to search and order over 50M unique structures and 76M part numbers, including 4.5M building blocks and 20.3M screening compounds from 210+ suppliers. Offers compound reformatting, inventory management and global distribution, a virtual chemical space of over 4.9 trillion compounds for drug discovery, and structure data downloads for virtual screening, lead optimization, and cheminformatics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full eMolecules company profile →
Prelude Dynamics
HQ: United States
Website
- Description: Provider of innovative software for human and veterinary clinical trials, including VISION, the only Clinical Trial Optimization Platform (CTOP) available in the industry. Offerings include a web-based EDC for compliant data collection, an ePRO mobile app for participant data entry, and professional services with Customer Success Managers for study design and implementation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prelude Dynamics company profile →
Integromics
HQ: Spain
Website
- Description: Provider of bioinformatics software solutions for life sciences, focused on data management and advanced validated analysis in genomics and proteomics, enabling scientists to organize data, perform analyses, and discover new biomedical knowledge; operating in the global life sciences market with a network of collaborations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Integromics company profile →
InfoChem
HQ: Germany
Website
- Description: Provider of software solutions for chemical information, focusing on the production and marketing of new products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full InfoChem company profile →
Adimab
HQ: United States
Website
- Description: Provider of an antibody discovery and optimization platform developing full-length human Immunoglobulin Gs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Adimab company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Clarivate
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Clarivate
2.2 - Growth funds investing in similar companies to Clarivate
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Clarivate
4.2 - Public trading comparable groups for Clarivate
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →